AG00F9X0

65710-07-8 | Apramycin (sulfate)

AG00F9X0

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	65710-07-8
Catalog Number	AG00F9X0(AGN-PC-0THU6G)
Chemical Name	Apramycin (sulfate)
EC Number	265-890-7
IUPAC Name	(2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric acid
InChI	InChI=1S/C21H41N5O11.H2O4S/c1-26-11-14(30)18-8(33-20(11)37-21-16(32)13(29)10(25)9(4-27)34-21)3-7(24)19(36-18)35-17-6(23)2-5(22)12(28)15(17)31;1-5(2,3)4/h5-21,26-32H,2-4,22-25H2,1H3;(H2,1,2,3,4)/t5-,6+,7-,8+,9-,10-,11+,12+,13+,14-,15-,16-,17-,18+,19+,20-,21-;/m1./s1
InChI Key	WGLYHYWDYPSNPF-RQFIXDHTSA-N
MDL Number	MFCD06200257
Molecular Formula	C21H43N5O15S
Molecular Weight	637.6556
SMILES	O[C@H]1[C@@H](O[C@@H]2[C@@H](NC)[C@@H](O)[C@]3([H])[C@@](C[C@@H](N)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@H](N)C[C@@H]4N)O3)([H])O2)O[C@H](CO)[C@@H](N)[C@@H]1O.O=S(O)(O)=O
UNII	8UYL6NAZ3Q
Synonyms	apramycin, apramycin sulfate, Apramycin sulfate, 65710-07-8, Apramycin sulphate, Apramycin (sulfate), Apramycin sulfate salt, UNII-8UYL6NAZ3Q, 8UYL6NAZ3Q, AI3-29795, 41194-16-5, apramycin-sulfate, AK116531, EINECS 265-890-7, AC1MIX48, Apramycin, sulfate (2:5), SCHEMBL94999, ZX-AFC000483, 410097-64-2, HY-B1329, MFCD06200257, s4254, AKOS016010323, CS-4854, Apramycin sulfate salt, >=95% (TLC), AN-38587, AS-35223, ST24045979, ST51012397, 710A078, ino-6-(hydroxymethyl)oxane-3,4-diol;sulfuric acid, W-104790, Apramycin Sulfate, Antibiotic for Culture Media Use Only, (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxy-cyclohexoxy]-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)tetrahydropyran-3,4-diol; sulfuric, (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-am, (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol; sulfuric acid, D-Streptamine, O-4-amino-4-deoxy-alpha-D-glucopyranosyl-(1-8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octadialdo-1,5:8,4-dipyranosyl-(1-4)-2-deoxy-, sulfate (salt), Nebramycin II, apramycin, Apramicina, Apramycine, Apramycinum, Ambylan, Apralan, Ampramycin sulfate, Nebramycin factor 2, Apramycine [INN-French], Apramycinum [INN-Latin], Apramicina [INN-Spanish], Apramycin [USAN:BAN:INN], Apramycin [USAN:INN:BAN], UNII-388K3TR36Z, C21H41N5O11.xH2O4S, C21H41N5O11, EINECS 253-460-1, EL 857, C21-H41-N5-O11, CID3081544, Apramycin sulfate salt, 95% - 1G 1g, B1665, C21-H41-N5-O11.x-H2-O4-S, EL-857/820, 37321-09-8, 4-O-((8R)-2-Amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl)-2-deoxy-D-streptamine, 4-O-(3alpha-Amino-6alpha-((4-amino-4-deoxy-alpha-D-glucopyranosyl)oxy)-2,3,4,5abeta,6,7,8,8aalpha-octahydro-8beta-hydroxy-7beta-(methylamino)pyrano(3,2-b)pyran-2alpha-yl)-2-deoxy-D-streptamine, D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1.fwdarw.4)-2-deoxy-, D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1?8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1?4)-2-deoxy-, D-Streptamine, O-4-amino-4-deoxy-.alpha.-D-glucopyranosyl-(1?8)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-.alpha.-D-allo-octodialdo-1,5:8,4-dipyranosyl-(1?4)-2-deoxy-, sulfate (salt), D-Streptamine, O-4-amino-4-deoxy-a-D-glucopyranosyl-(18)-O-(8R)-2-amino-2,3,7-trideoxy-7-(methylamino)-D-glycero-a-D-allo-octodialdo-1,5:8,4-dipyranosyl-(14)-2-deoxy-, sulfate (1:),

Complexity	841
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	17
Defined Bond Stereocenter Count	0
Exact Mass	637.248g/mol
Formal Charge	0
Heavy Atom Count	42
Hydrogen Bond Acceptor Count	20
Hydrogen Bond Donor Count	13
Isotope Atom Count	0
Molecular Weight	637.655g/mol
Monoisotopic Mass	637.248g/mol
Rotatable Bond Count	6
Topological Polar Surface Area	367A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H360
Packing Group	Ⅲ
Precautionary statements	P201-P308+P313
UN Code	UN 2811

Certificate of Analysis

Lot Number